Skip to main navigation Skip to search Skip to main content

Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4

  • Michael J. Hafey
  • , Lauren M. Aleksunes
  • , Christy C. Bridges
  • , Kenneth R. Brouwer
  • , Huan Chieh Chien
  • , Elaine M. Leslie
  • , Shuiying Hu
  • , Yang Li
  • , Jinshan Shen
  • , Alex Sparreboom
  • , Jason Sprowl
  • , Donald Tweedie
  • , Yurong Lai
  • Merck
  • Rutgers - The State University of New Jersey, New Brunswick
  • Mercer University
  • BioIVT
  • Amgen Incorporated
  • University of Alberta
  • Ohio State University
  • Relay Therapeutics
  • Independent Consultant
  • Gilead Sciences, Inc.

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Over the last decade, significant progress been made in elucidating the role of membrane transporters in altering drug disposition, with important toxicological consequences due to changes in localized concentrations of compounds. The topic of “Transporters and Toxicity” was recently highlighted as a scientific session at the International Transporter Consortium (ITC) Workshop 4 in 2021. The current white paper is not intended to be an extensive review on the topic of transporters and toxicity but an opportunity to highlight aspects of the role of transporters in various toxicities with clinically relevant implications as covered during the session. This includes a review of the role of solute carrier transporters in anticancer drug-induced organ injury, transporters as key players in organ barrier function, and the role of transporters in metal/metalloid toxicity.

Original languageEnglish
Pages (from-to)527-539
Number of pages13
JournalClinical Pharmacology and Therapeutics
Volume112
Issue number3
DOIs
StatePublished - Sep 2022

Fingerprint

Dive into the research topics of 'Transporters and Toxicity: Insights From the International Transporter Consortium Workshop 4'. Together they form a unique fingerprint.

Cite this